INO earnings call for the period ending December 31, 2024.
Image source: The Motley Fool.
Inovio Pharmaceuticals (INO -1.42%)
Q4 2024 Earnings Call
Mar 18, 2025, 4:30 p.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Operator
Good afternoon, ladies and gentlemen, and welcome to the INOVIO Pharmaceuticals fourth quarter 2024 financial results conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator instructions] This call is being recorded on Tuesday, March 18, 2025.
And I would now like to turn the conference over to Ms. Jenny Wilson. Thank you. Please go ahead.
Jennie Wilson — Investor Relations
Good afternoon, and thank you for joining the INOVIO fourth quarter 2024 financial results conference call. Joining me on today’s call will be Dr. Jackie Shea, president and chief executive officer; Dr. Mike Sumner, chief medical officer; Peter Kies, chief financial officer; and Steve Egge, chief commercial officer.
Today’s call will review our corporate and financial information for the quarter and year ended December 31st, 2024, as well as provide a general business update. Following prepared remarks, we will conduct a question-and-answer segment. During the call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our business plans to develop INOVIO’s DNA medicines platform, which include clinical and regulatory developments and timing of clinical data readouts and planned regulatory submissions, along with capital resources and strategic matters.
